Treatment of scleromyxedema with 2-chlorodeoxyadenosine

Loretta S. Davis, Salahattin Sanal, Omar P. Sangueza

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Scleromyxedema is an unusual skin disease that is characterized by a proliferation of fibroblasts and an accumulation of mucin. Despite experience with multiple forms of therapy, no single agent has proved uniformly beneficial in this condition. We describe a patient with scleromyxedema who was treated successfully with 2-chlorodeoxyadenosine (2-CdA), a purine analog used mainly in the treatment of lymphoproliferative disorders.

Original languageEnglish (US)
Pages (from-to)288-290
Number of pages3
JournalJournal of the American Academy of Dermatology
Volume35
Issue number2 II
DOIs
StatePublished - Aug 1996

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Treatment of scleromyxedema with 2-chlorodeoxyadenosine'. Together they form a unique fingerprint.

  • Cite this